Cargando…

The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs

The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmnäs-Bédard, Marie S A, Costabile, Giuseppina, Vetrani, Claudia, Åberg, Sebastian, Hjalmarsson, Yommine, Dicksved, Johan, Riccardi, Gabriele, Landberg, Rikard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535511/
https://www.ncbi.nlm.nih.gov/pubmed/36026526
http://dx.doi.org/10.1093/ajcn/nqac217
_version_ 1784802788230823936
author Palmnäs-Bédard, Marie S A
Costabile, Giuseppina
Vetrani, Claudia
Åberg, Sebastian
Hjalmarsson, Yommine
Dicksved, Johan
Riccardi, Gabriele
Landberg, Rikard
author_facet Palmnäs-Bédard, Marie S A
Costabile, Giuseppina
Vetrani, Claudia
Åberg, Sebastian
Hjalmarsson, Yommine
Dicksved, Johan
Riccardi, Gabriele
Landberg, Rikard
author_sort Palmnäs-Bédard, Marie S A
collection PubMed
description The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 diabetes prevention, but human observational studies reporting on such findings have not been extensively reviewed. Here, we review the literature on associations between gut microbiota and markers and stages of glucose dysregulation and insulin resistance in healthy adults and in adults with metabolic disease and risk factors. We present the current evidence for identified key bacteria and their potential roles in glucose metabolism independent of overweight, obesity, and metabolic drugs. We provide support for SCFAs mediating such effects and discuss the role of diet, as well as metabolites derived from diet and gut microbiota interactions. From 5983 initially identified PubMed records, 45 original studies were eligible and reviewed. α Diversity and 45 bacterial taxa were associated with selected outcomes. Six taxa were most frequently associated with glucose metabolism: Akkermansia muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium (inversely associated) and Dorea (directly associated). For Dorea and A. muciniphila, associations were independent of metabolic drugs and body measures. For A. muciniphila and F. prausnitzii, limited evidence supported SCFA mediation of potential effects on glucose metabolism. We conclude that observational studies applying metagenomics sequencing to identify species-level relations are warranted, as are studies accounting for confounding factors and investigating SCFA and postprandial glucose metabolism. Such advances in the field will, together with mechanistic and prospective studies and investigations into diet–gut microbiota interactions, have the potential to bring critical insight into roles of gut microbiota and microbial metabolites in human glucose metabolism and to contribute toward the development of novel prevention strategies for type 2 diabetes, including precision nutrition.
format Online
Article
Text
id pubmed-9535511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95355112022-10-07 The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs Palmnäs-Bédard, Marie S A Costabile, Giuseppina Vetrani, Claudia Åberg, Sebastian Hjalmarsson, Yommine Dicksved, Johan Riccardi, Gabriele Landberg, Rikard Am J Clin Nutr Narrative Review The gut microbiota plays a fundamental role in human nutrition and metabolism and may have direct implications for type 2 diabetes and associated preconditions. An improved understanding of relations between human gut microbiota and glucose metabolism could lead to novel opportunities for type 2 diabetes prevention, but human observational studies reporting on such findings have not been extensively reviewed. Here, we review the literature on associations between gut microbiota and markers and stages of glucose dysregulation and insulin resistance in healthy adults and in adults with metabolic disease and risk factors. We present the current evidence for identified key bacteria and their potential roles in glucose metabolism independent of overweight, obesity, and metabolic drugs. We provide support for SCFAs mediating such effects and discuss the role of diet, as well as metabolites derived from diet and gut microbiota interactions. From 5983 initially identified PubMed records, 45 original studies were eligible and reviewed. α Diversity and 45 bacterial taxa were associated with selected outcomes. Six taxa were most frequently associated with glucose metabolism: Akkermansia muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium (inversely associated) and Dorea (directly associated). For Dorea and A. muciniphila, associations were independent of metabolic drugs and body measures. For A. muciniphila and F. prausnitzii, limited evidence supported SCFA mediation of potential effects on glucose metabolism. We conclude that observational studies applying metagenomics sequencing to identify species-level relations are warranted, as are studies accounting for confounding factors and investigating SCFA and postprandial glucose metabolism. Such advances in the field will, together with mechanistic and prospective studies and investigations into diet–gut microbiota interactions, have the potential to bring critical insight into roles of gut microbiota and microbial metabolites in human glucose metabolism and to contribute toward the development of novel prevention strategies for type 2 diabetes, including precision nutrition. Oxford University Press 2022-08-26 /pmc/articles/PMC9535511/ /pubmed/36026526 http://dx.doi.org/10.1093/ajcn/nqac217 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Narrative Review
Palmnäs-Bédard, Marie S A
Costabile, Giuseppina
Vetrani, Claudia
Åberg, Sebastian
Hjalmarsson, Yommine
Dicksved, Johan
Riccardi, Gabriele
Landberg, Rikard
The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
title The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
title_full The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
title_fullStr The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
title_full_unstemmed The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
title_short The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
title_sort human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of scfas
topic Narrative Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535511/
https://www.ncbi.nlm.nih.gov/pubmed/36026526
http://dx.doi.org/10.1093/ajcn/nqac217
work_keys_str_mv AT palmnasbedardmariesa thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT costabilegiuseppina thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT vetraniclaudia thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT abergsebastian thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT hjalmarssonyommine thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT dicksvedjohan thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT riccardigabriele thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT landbergrikard thehumangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT palmnasbedardmariesa humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT costabilegiuseppina humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT vetraniclaudia humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT abergsebastian humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT hjalmarssonyommine humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT dicksvedjohan humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT riccardigabriele humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas
AT landbergrikard humangutmicrobiotaandglucosemetabolismascopingreviewofkeybacteriaandthepotentialroleofscfas